The world economy is collapsing because of the terror and mounting death toll caused by the Coronavirus pandemic. But the anti-malarial drug chloroquine is effective both as a prophylactic and treatment for the virus – and the medical establishment has known about this since at least the SARS coronavirus outbreak in 2005. What the hell is going on?
Yesterday, I reported the existence of three studies, all claiming that chloroquine phosphate had proved effective in treating the COVID-19.
This has since been confirmed by a more recent open-label non-randomised clinical trial in France by Didier Raoult M.D/Ph.D et al, completed just days ago. The sample was small but the results were convincing.
As the summary reports:
100% of patients that received a combination of HCQ and Azithromycin tested negative and were virologically cured within 6 days of treatment.
In addition, recent guidelines from South Korea and China report that hydroxychloroquine and chloroquine are effective antiviral therapeutic treatments for novel coronavirus.
But the story gets more extraordinary still. It turns out that the Centers for Disease Control and Prevention (CDC) has known since at least 2005 that chloroquine is effective against coronaviruses.
Dr. Harvey Risch, an epidemiology professor at Yale School of Public Health, said on Tuesday that he thinks hydroxychloroquine could save 75,000 to 100,000 lives if the drug is widely used to treat coronavirus.
“There are many doctors that I’ve gotten hostile remarks about saying that all the evidence is bad for it and, in fact, that is not true at all,” Risch told “Ingraham Angle,” adding that he believes the drug can be used as a “prophylactic” for front-line workers, as other countries like India have done.
Risch lamented that a “propaganda war” is being waged against the use of the drug for political purposes, not based on “medical facts.”
Preliminary Injunction Sought to Release Hydroxychloroquine to the Public – Today the Association of American Physicians & Surgeons filed its motion for a preliminary injunction to compel release to the public of hydroxychloroquine by the Food & Drug Administration (FDA) and the Department of Health & Human Services (HHS), in AAPS v. HHS, No. 1:20-cv-00493-RJJ-SJB (W.D. Mich.). Nearly 100 million doses of hydroxychloroquine (HCQ) were donated to these agencies, and yet they have not released virtually any of it to the public.
Millions of Americans fear attending political gatherings, religious services, and even large family get-togethers without the availability of early treatment if they were to contract COVID-19. Why should Americans have to wait until they or a loved one is on a ventilator before they gain access to medication to overcome this virus?
“Why does the government continue to withhold more than 60 million doses of HCQ from the public?” asks Jane Orient, M.D., the Executive Director of AAPS. “This potentially life-saving medication is wasting away in government warehouses while Americans are dying from COVID-19.”